Overview

Effect of HMP on Diabetic Microangiopaemia in T2DM

Status:
Not yet recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
The study mainly investigates the therapeutic effect of Heart-Protecting Musk Pill (HMP) on patients with diabetic microangiopathy. According to the indicators of diabetic nephropathy (DN), diabetic retinopathy (DR), oxidative stress and inflammatory factor in patients with diabetic microvascular disease after using HMP, we aim to evaluate the effect of HMP on diabetic microangiopathy, oxidative stress and inflammation.
Phase:
Phase 4
Details
Lead Sponsor:
Affiliated Hospital of Nantong University
Treatments:
Calcium Dobesilate
Valsartan